Inventor

KORMAN ALAN J

US84 patents

⚠️ This page may combine multiple inventors who share the name “KORMAN ALAN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KORMAN ALAN J

SQUIBB & SONS LLC

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Monoclonal antibodies to Programmed Death 1 (PD-1)

Methods for treating cancer using anti-PD-1 antibodies

Monoclonal antibodies to programmed death 1 (PD-1)

Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Monoclonal antibodies to programmed death 1 (PD-1)

Human monoclonal antibodies to O8E

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof

BRISTOL MYERS SQUIBB CO

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Anti-ICOS agonist antibodies and uses thereof

Ipilimumab variant with enhanced ADCC

Antibodies against CD73 and uses thereof

Antibodies against CD73

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies comprising modified heavy constant regions

Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors

Anti-ICOS agonist antibodies and uses thereof

MEDAREX INC

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)

Human CTLA-4 antibodies and their uses

Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Human CTLA-4 antibodies and their uses

Human CTLA-4 antibodies

Methods of treatment using CTLA-4 antibodies

KORMAN ALAN J

Monoclonal antibodies to programmed death 1 (PD-1)

Human CTLA-4 antibodies and their uses

Human monoclonal antibodies to O8E

Human CTLA-4 antibodies and their uses

LI BETTY

PS-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof

PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof

MEDAREX LLC

Methods for treating cancer using anti-PD-1 antibodies

NEXSTAR PHARMACEUTICALS INC

Nucleic acid ligands to CD40ligand

MATARAZA JENNIFER MARIE

Fully human antibodies to BTLA

KUHNE MICHELLE

Human monoclonal antibodies that bind CXCR4

DAVIS THOMAS ANDREW

Methods of treatment using CTLA-4 antibodies